These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16984814)

  • 1. Intracellular targeting of phosphodiesterase-4 underpins compartmentalized cAMP signaling.
    Lynch MJ; Hill EV; Houslay MD
    Curr Top Dev Biol; 2006; 75():225-59. PubMed ID: 16984814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.
    Houslay MD; Adams DR
    Biochem J; 2003 Feb; 370(Pt 1):1-18. PubMed ID: 12444918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
    Houslay MD; Baillie GS; Maurice DH
    Circ Res; 2007 Apr; 100(7):950-66. PubMed ID: 17431197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm for understanding the unique non-redundant roles that PDE4 isoforms play in shaping compartmentalized cAMP cell signalling.
    Lynch MJ; Baillie GS; Houslay MD
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):938-41. PubMed ID: 17956250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP phosphodiesterase-4A1 (PDE4A1) has provided the paradigm for the intracellular targeting of phosphodiesterases, a process that underpins compartmentalized cAMP signalling.
    Huston E; Houslay TM; Baillie GS; Houslay MD
    Biochem Soc Trans; 2006 Aug; 34(Pt 4):504-9. PubMed ID: 16856845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways.
    Houslay MD; Baillie GS
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1186-90. PubMed ID: 14641023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes.
    Baillie GS; Houslay MD
    Curr Opin Cell Biol; 2005 Apr; 17(2):129-34. PubMed ID: 15780588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
    Chini CC; Grande JP; Chini EN; Dousa TP
    J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene.
    Wallace DA; Johnston LA; Huston E; MacMaster D; Houslay TM; Cheung YF; Campbell L; Millen JE; Smith RA; Gall I; Knowles RG; Sullivan M; Houslay MD
    Mol Pharmacol; 2005 Jun; 67(6):1920-34. PubMed ID: 15738310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module.
    Dodge KL; Khouangsathiene S; Kapiloff MS; Mouton R; Hill EV; Houslay MD; Langeberg LK; Scott JD
    EMBO J; 2001 Apr; 20(8):1921-30. PubMed ID: 11296225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells.
    Stefan E; Wiesner B; Baillie GS; Mollajew R; Henn V; Lorenz D; Furkert J; Santamaria K; Nedvetsky P; Hundsrucker C; Beyermann M; Krause E; Pohl P; Gall I; MacIntyre AN; Bachmann S; Houslay MD; Rosenthal W; Klussmann E
    J Am Soc Nephrol; 2007 Jan; 18(1):199-212. PubMed ID: 17135396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels.
    Murdoch H; Mackie S; Collins DM; Hill EV; Bolger GB; Klussmann E; Porteous DJ; Millar JK; Houslay MD
    J Neurosci; 2007 Aug; 27(35):9513-24. PubMed ID: 17728464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keynote review: phosphodiesterase-4 as a therapeutic target.
    Houslay MD; Schafer P; Zhang KY
    Drug Discov Today; 2005 Nov; 10(22):1503-19. PubMed ID: 16257373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in Leydig cell function with phosphoproteomics.
    Golkowski M; Shimizu-Albergine M; Suh HW; Beavo JA; Ong SE
    Cell Signal; 2016 Jul; 28(7):764-78. PubMed ID: 26643407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis.
    Omar B; Zmuda-Trzebiatowska E; Manganiello V; Göransson O; Degerman E
    Cell Signal; 2009 May; 21(5):760-6. PubMed ID: 19167487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells.
    Millen J; MacLean MR; Houslay MD
    Eur J Cell Biol; 2006 Jul; 85(7):679-91. PubMed ID: 16458997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase gene.
    Johnston LA; Erdogan S; Cheung YF; Sullivan M; Barber R; Lynch MJ; Baillie GS; Van Heeke G; Adams DR; Huston E; Houslay MD
    Biochem J; 2004 Jun; 380(Pt 2):371-84. PubMed ID: 15025561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of extracellular signal-regulated kinase 2 mitogen-activated protein kinase phosphorylation and regulation of activity of PDE4 cyclic adenosine monophosphate-specific phosphodiesterases.
    Hill EV; Houslay MD; Baillie GS
    Methods Mol Biol; 2005; 307():225-37. PubMed ID: 15988067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site.
    Grange M; Sette C; Cuomo M; Conti M; Lagarde M; Prigent AF; Némoz G
    J Biol Chem; 2000 Oct; 275(43):33379-87. PubMed ID: 10938092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.